Home » 21: Short TeRm intensified pembrolizumab (KEytruda) and tivozanib for Hogh-Risk renal cell carcinoma—STRIKE! (A033201) – NCT06661720 – PMC

21: Short TeRm intensified pembrolizumab (KEytruda) and tivozanib for Hogh-Risk renal cell carcinoma—STRIKE! (A033201) – NCT06661720 – PMC

by Bradley A McGregor | Oct 10, 2025 | Articles | 0 Comments